OTCMKTS:PHCEF

Pharmacielo Competitors

$1.44
+0.02 (+1.41 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.40
Now: $1.44
$1.47
50-Day Range
$1.25
MA: $1.81
$2.42
52-Week Range
$1.90
Now: $1.44
$9.98
Volume12,644 shs
Average Volume64,155 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Pharmacielo (OTCMKTS:PHCEF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying PHCEF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Pharmacielo, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Pharmacielo (OTCMKTS:PHCEF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Pharmacielo and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmacieloN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Valuation and Earnings

This table compares Pharmacielo and Abacus Health Products' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmacieloN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Pharmacielo and Abacus Health Products, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmacielo0000N/A
Abacus Health Products0000N/A

Acreage (OTCMKTS:ACRGF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Acreage and Pharmacielo, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Pharmacielo0000N/A

Acreage currently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher possible upside, equities research analysts clearly believe Acreage is more favorable than Pharmacielo.

Profitability

This table compares Acreage and Pharmacielo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
PharmacieloN/AN/AN/A

Valuation & Earnings

This table compares Acreage and Pharmacielo's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
PharmacieloN/AN/AN/AN/AN/A

Summary

Acreage beats Pharmacielo on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Applied Biosciences and Pharmacielo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Pharmacielo0000N/A

Profitability

This table compares Applied Biosciences and Pharmacielo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
PharmacieloN/AN/AN/A

Earnings and Valuation

This table compares Applied Biosciences and Pharmacielo's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
PharmacieloN/AN/AN/AN/AN/A

Ayr Strategies (OTCMKTS:AYRSF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Ayr Strategies and Pharmacielo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Pharmacielo0000N/A

Ayr Strategies currently has a consensus price target of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, research analysts clearly believe Ayr Strategies is more favorable than Pharmacielo.

Profitability

This table compares Ayr Strategies and Pharmacielo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
PharmacieloN/AN/AN/A

Earnings and Valuation

This table compares Ayr Strategies and Pharmacielo's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
PharmacieloN/AN/AN/AN/AN/A

Summary

Ayr Strategies beats Pharmacielo on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Can B and Pharmacielo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Pharmacielo0000N/A

Profitability

This table compares Can B and Pharmacielo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
PharmacieloN/AN/AN/A

Earnings and Valuation

This table compares Can B and Pharmacielo's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
PharmacieloN/AN/AN/AN/AN/A

Cansortium (OTCMKTS:CNTMF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Cansortium and Pharmacielo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Pharmacielo0000N/A

Cansortium currently has a consensus price target of $1.20, suggesting a potential upside of 41.18%. Given Cansortium's higher probable upside, research analysts clearly believe Cansortium is more favorable than Pharmacielo.

Profitability

This table compares Cansortium and Pharmacielo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
PharmacieloN/AN/AN/A

Earnings and Valuation

This table compares Cansortium and Pharmacielo's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
PharmacieloN/AN/AN/AN/AN/A

Summary

Cansortium beats Pharmacielo on 2 of the 2 factors compared between the two stocks.


Pharmacielo Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84+5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77+0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.25+92.0%$0.00N/A0.00High Trading Volume
Gap Up
AYRSF
Ayr Strategies
1.4$21.26+0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.55+1.8%$0.00N/A0.00High Trading Volume
Cansortium logo
CNTMF
Cansortium
1.1$0.85+2.4%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.51+0.9%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10+9.6%$0.00N/A0.00Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.08+0.9%$0.00N/A0.00Gap Up
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22+9.1%$0.00N/A0.00Gap Up
Cosmos logo
COSM
Cosmos
0.5$5.80+0.9%$0.00N/A0.00
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.73+1.1%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.70+0.1%$0.00N/A0.00News Coverage
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00+0.0%$0.00N/A0.00Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15+3.4%$0.00N/A0.00Gap Up
EVIO
EVIO
0.6$0.00+0.0%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28+3.6%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05+0.0%$0.00N/A0.00News Coverage
Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01+0.0%$0.00N/A0.00News Coverage
Gap Up
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.10+3.9%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.62+3.2%$0.00N/A0.00Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06+2.0%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01+0.0%$0.00N/A0.00Gap Down
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68+0.0%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.24+7.5%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.36+0.0%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04+0.0%$0.00N/A0.00Gap Up
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06+16.4%$0.00N/A0.00Gap Up
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.45+0.9%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.22+0.2%$0.00N/A0.00High Trading Volume
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01+0.0%$0.00N/A0.00News Coverage
Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.06+0.0%$0.00N/A0.00Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.42+7.2%$0.00N/A0.00News Coverage
Gap Up
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.37+2.7%$0.00N/A0.00Gap Up
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.31+1.4%$0.00N/A0.00High Trading Volume
MJardin Group logo
MJARF
MJardin Group
1.1$0.07+0.0%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02+0.0%$0.00N/A0.00News Coverage
Gap Down
Plus Products logo
PLPRF
Plus Products
1.1$0.57+0.9%$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00+4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70+0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01+0.0%$0.00N/A0.00News Coverage
Gap Down
SANP
Santo Mining
0.5$0.01+0.0%$0.00N/A0.00News Coverage
Gap Down
SGIOY
Shionogi & Co., Ltd.
0.5$13.39+1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40+7.8%$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$10.11+2.4%$0.00N/A0.00Gap Down
The Flowr logo
FLWPF
The Flowr
1.5$0.26+3.8%$0.00N/A0.00Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.32+0.0%$0.00N/A0.00Analyst Downgrade
News Coverage
Gap Up
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.